Legal & General Group PLC Seres Therapeutics, Inc. Transaction History

Legal & General Group PLC

  • $420 Billion
  • Q1 2024

A detailed history of Legal & General Group PLC transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Legal & General Group PLC holds 9,985 shares of MCRB stock, worth $7,189. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9,985
Previous 14,489 31.09%
Holding current value
$7,189
Previous $20,000 65.0%
% of portfolio
0.0%
Previous 0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 14, 2024
SELL
$0.75 - $1.56 $3,378 - $7,026
-4,504 Reduced 31.09%
9,985 $7,000
Q4 2023

Feb 15, 2024
SELL
$0.93 - $2.15 $66,216 - $153,080
-71,200 Reduced 83.09%
14,489 $20,000
Q3 2023

Nov 14, 2023
SELL
$2.33 - $5.07 $2,232 - $4,857
-958 Reduced 1.11%
85,689 $203,000
Q2 2023

Aug 14, 2023
BUY
$4.67 - $6.55 $207,086 - $290,453
44,344 Added 104.82%
86,647 $415,000
Q1 2023

May 15, 2023
BUY
$4.95 - $6.09 $12,573 - $15,468
2,540 Added 6.39%
42,303 $239,000
Q4 2022

Feb 14, 2023
BUY
$5.09 - $9.05 $2,998 - $5,330
589 Added 1.5%
39,763 $222,000
Q3 2022

Nov 14, 2022
BUY
$3.5 - $7.2 $34,475 - $70,920
9,850 Added 33.59%
39,174 $252,000
Q2 2022

Aug 22, 2022
BUY
$2.7 - $7.62 $753 - $2,125
279 Added 0.96%
29,324 $100,000
Q1 2022

May 16, 2022
SELL
$6.3 - $8.84 $409 - $574
-65 Reduced 0.22%
29,045 $207,000
Q4 2021

Feb 14, 2022
BUY
$6.02 - $11.43 $216 - $411
36 Added 0.12%
29,110 $242,000
Q3 2021

Nov 15, 2021
BUY
$5.46 - $22.6 $73,846 - $305,665
13,525 Added 86.98%
29,074 $202,000
Q2 2021

Aug 12, 2021
BUY
$18.46 - $24.36 $24,348 - $32,130
1,319 Added 9.27%
15,549 $371,000
Q1 2021

May 17, 2021
SELL
$17.66 - $28.92 $8,865 - $14,517
-502 Reduced 3.41%
14,230 $294,000
Q4 2020

Feb 12, 2021
BUY
$23.25 - $37.73 $193,091 - $313,347
8,305 Added 129.22%
14,732 $361,000
Q3 2020

Nov 13, 2020
SELL
$3.74 - $28.74 $3,033 - $23,308
-811 Reduced 11.2%
6,427 $182,000
Q2 2020

Aug 14, 2020
BUY
$3.04 - $6.2 $5,259 - $10,726
1,730 Added 31.41%
7,238 $34,000
Q1 2020

May 14, 2020
SELL
$2.64 - $3.82 $5,470 - $7,915
-2,072 Reduced 27.34%
5,508 $20,000
Q4 2019

Feb 13, 2020
BUY
$2.99 - $4.42 $4,434 - $6,554
1,483 Added 24.32%
7,580 $26,000
Q3 2019

Nov 13, 2019
BUY
$2.29 - $4.16 $6,219 - $11,298
2,716 Added 80.33%
6,097 $24,000
Q1 2018

May 17, 2018
SELL
$7.34 - $11.16 $10,268 - $15,612
-1,399 Reduced 29.27%
3,381 $25,000
Q4 2017

Feb 13, 2018
BUY
$9.15 - $12.64 $43,737 - $60,419
4,780
4,780 $48,000

Others Institutions Holding MCRB

# of Institutions
100
Shares Held
62.7M
Call Options Held
36.9K
Put Options Held
476K
View Full List

About Seres Therapeutics, Inc.

MCRB Quotes by TradingView
  • Ticker MCRB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 124,072,000
  • Market Cap $89.3M
  • Description
  • Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...
More about MCRB
Track This Portfolio

Track Legal & General Group PLC Portfolio

Follow Legal & General Group PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email